Stock Events

Stock Events

Giant Biogene 

$3.65
0
+$0+0% Wednesday 12:05

Statistics

Day High
-
Day Low
-
52W High
4.22
52W Low
4.22
Volume
-
Avg. Volume
-
Mkt Cap
3.91B
P/E Ratio
-
Dividend Yield
2.3%
Dividend
0.08

Upcoming

17
JUN
Dividend Ex
Estimated
 
28
AUG
Dividend Payment
Estimated
 
17
JUN 27
Dividend Ex
Estimated
 
27
AUG 27
Dividend Payment
Estimated
 

Dividends

2.3%Dividend Yield
Aug 25
$0.08
Aug 25
$0.08
Jul 24
$0.06
Jul 24
$0.06
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

19MarExpected
Q4 2024
Q2 2025
Q4 2025
0.1
0.12
0.14
0.16
Expected EPS
0.0986424
Actual EPS
0.0972128

Financials

37.24%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
1.52BRevenue
565.83MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow GBHCF. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Changchun High-Tech Industry (Group).
000661.SZ
Mkt Cap65.8B
Chengdu Kanghong Pharmaceutical Group is directly competing in the biopharmaceutical sector focusing on similar therapeutic areas.
Chongqing Zhifei Biological Products Company
300122.SZ
Mkt Cap129.6B
WuXi AppTec provides a broad range of R&D and manufacturing services that support the biopharmaceutical industry, competing in the same service space.
Walvax Biotechnology Company
300142.SZ
Mkt Cap55.24B
WuXi Biologics offers biologics development and manufacturing, directly competing with Giant Biogene's biopharmaceutical products.
Asymchem Laboratories (Tianjin)
002821.SZ
Mkt Cap48.16B
Asymchem Laboratories specializes in providing drug R&D and manufacturing services, competing in the pharmaceutical services market.
Shenzhen Kangtai Biological Products
300601.SZ
Mkt Cap34.83B
Fosun Pharma specializes in pharmaceutical manufacturing and healthcare services, competing in both the domestic and international markets.
Shanghai Raas Blood Products
002252.SZ
Mkt Cap43.48B
Livzon Pharmaceutical Group manufactures pharmaceuticals and biological medicines, competing in similar product categories.
Livzon Pharmaceutical Group
000513.SZ
Mkt Cap30.26B
Yunnan Baiyao Group is known for its traditional and modern Chinese medicine products, competing in the broader pharmaceutical market in China.

About

Giant Biogene Holding Co., Ltd., an investment holding company, engages in the research, development, manufacture, and sale of bioactive material-based beauty and health products in the People's Republic of China. It also manufactures rare ginsenosides technology-based functional foods; and offers medical devices. The company offers its functional skincare products, medical dressings, and functional foods primarily under the Comfy, Collgene, Keyu, Kehen, Kefuping, Leeyen, SKIGIN, and Shengan brands. Giant Biogene Holding Co., Ltd. was founded in 2000 and is headquartered in Xi'an, the People's Republic of China.
Show more...
CEO
Mr. Wesley Siemens
Country
United States
ISIN
KYG3887G1091

Listings

OTC Link
US
GBHCF
HK
HK
2367.HK

0 Comments

Share your thoughts

FAQ

What is Giant Biogene stock price today?▼
The current price of GBHCF is $3.65 USD — it has increased by +0% in the past 24 hours. Watch Giant Biogene stock price performance more closely on the chart.
What is Giant Biogene stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Giant Biogene stocks are traded under the ticker GBHCF.
What is Giant Biogene market cap?▼
Today Giant Biogene has the market capitalization of 3.91B
When is the next Giant Biogene earnings date?▼
Giant Biogene is going to release the next earnings report on September 01, 2026.
What were Giant Biogene earnings last quarter?▼
GBHCF earnings for the last quarter are 0.1 USD per share, whereas the estimation was 0.1 USD resulting in a -1.45% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Giant Biogene revenue for the last year?▼
Giant Biogene revenue for the last year amounts to 1.52B USD.
What is Giant Biogene net income for the last year?▼
GBHCF net income for the last year is 565.83M USD.
Does Giant Biogene pay dividends?▼
Yes, GBHCF dividends are paid annual. The last dividend per share was 0.08 USD. As of today, Dividend Yield (FWD)% is 2.3%.
In which sector is Giant Biogene located?▼
Giant Biogene operates in the Materials sector.
When did Giant Biogene complete a stock split?▼
Giant Biogene has not had any recent stock splits.
Where is Giant Biogene headquartered?▼
Giant Biogene is headquartered in Calgary, United States.